Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30,207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Induction sintilimab and chemotherapy followed by concurrent chemoradiotherapy for locally advanced esophageal cancer: a proof-of-concept, single-arm, multicenter, phase 2 trial.
Ai D, Hao S, Shen W, Wu Q, Zhang S, Chen Y, Liu Q, Deng J, Zhu H, Chen K, Mo M, Gu D, Liu Y, Zhang Z, Zhou G, Hu J, Zhang Z, Ye J, Zhao K. Ai D, et al. Among authors: zhu h. EClinicalMedicine. 2024 Feb 6;69:102471. doi: 10.1016/j.eclinm.2024.102471. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38356729 Free PMC article.
Involved-Field Irradiation in Definitive Chemoradiotherapy for Locoregional Esophageal Squamous Cell Carcinoma: Results From the ESO-Shanghai 1 Trial.
Zhu H, Rivin Del Campo E, Ye J, Simone CB 2nd, Zhu Z, Zhao W, Amini A, Zhou J, Wu C, Tang H, Fan M, Li L, Lin Q, Xia Y, Li Y, Li J, Mo M, Jia H, Lu S, Wang J, Nie Y, Chen J, Wu S, Hamaji M, Haque W, Jeong BK, Shridhar R, Zhang Z, Chen Y, Zhao K. Zhu H, et al. Among authors: zhu z. Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1396-1406. doi: 10.1016/j.ijrobp.2021.02.053. Epub 2021 Mar 5. Int J Radiat Oncol Biol Phys. 2021. PMID: 33677048 Clinical Trial.
Dose escalation based on 18F-FDG PET/CT response in definitive chemoradiotherapy of locally advanced esophageal squamous cell carcinoma: a phase III, open-label, randomized, controlled trial (ESO-Shanghai 12).
Zhu H, Liu Q, Xu H, Mo M, Wang Z, Lu K, Zhou J, Chen J, Zheng X, Ye J, Ge X, Luo H, Liu Q, Deng J, Ai D, Hao S, Zhang J, Tseng IH, Song S, Chen Y, Zhao K. Zhu H, et al. Radiat Oncol. 2022 Jul 29;17(1):134. doi: 10.1186/s13014-022-02099-y. Radiat Oncol. 2022. PMID: 35906623 Free PMC article. Clinical Trial.
Radiotherapy for Advanced Esophageal Cancer: from Palliation to Curation.
Xin Z, Liu Q, Ai D, Chen K, Mariamidze E, Sumon MA, Devnani B, Pihlak R, Zhu H, Zhao K. Xin Z, et al. Among authors: zhu h. Curr Treat Options Oncol. 2023 Nov;24(11):1568-1579. doi: 10.1007/s11864-023-01134-8. Epub 2023 Oct 9. Curr Treat Options Oncol. 2023. PMID: 37812321 Review.
Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial.
Liu Q, Chen J, Lin Y, Ye J, Shen W, Luo H, Li B, Huang W, Wei S, Song J, Wang Y, Yang H, Lai S, Zhu H, Ai D, Chen Y, Deng J, Hao S, Zhao K. Liu Q, et al. Among authors: zhu h. Lancet Gastroenterol Hepatol. 2024 Jan;9(1):45-55. doi: 10.1016/S2468-1253(23)00316-3. Epub 2023 Nov 18. Lancet Gastroenterol Hepatol. 2024. PMID: 37980921 Clinical Trial.
30,207 results
You have reached the last available page of results. Please see the User Guide for more information.